The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now!

Thomas R Abrahamsson, Samuli Rautava, Aideen M Moore, Josef Neu, Philip M Sherman

Journal: The Journal of pediatrics 2014;165(2):389-94

PMID: 24948349

Full Text on Elsevier Science View on PubMed

Abstract

Address: Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Division of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. Electronic address: [email protected].; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.; Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; University of Florida, Gainesville, FL.

DOI: 10.1016/j.jpeds.2014.05.012

Link outs

Free resources

Medical:

https://clinicaltrials.gov/search?term=AREA%5BRefe...

Other Literature Sources:

https://scite.ai/reports/24948349

Subscription / membership required

Full Text Sources:

MeSH Terms: Clinical Trials as Topic, Enterocolitis, Necrotizing, Humans, Infant, Extremely Low Birth Weight, Infant, Newborn, Infant, Premature, North America, Probiotics, Treatment Outcome